Holdings (Monthly)
Guide ↗
Eaton Vance Worldwide Health Sciences Fund
· Eaton Vance Growth Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Feb 2026 | 85,543 | -6,863 | $94.5M | -2.8% | 12.47% | EC |
| 2 | AbbVie Inc | 00287Y109 | Feb 2026 | 224,713 | -21,559 | $48.9M | -14.4% | 6.46% | EC |
| 3 | Johnson & Johnson | 478160104 | Feb 2026 | 216,808 | — | $48.9M | -9.3% | 6.45% | EC |
| 4 | AstraZeneca PLC | 000000000 | Feb 2026 | 254,890 | +39,532 | $47.3M | +375.5% | 6.24% | EC |
| 5 | UnitedHealth Group Inc | 91324P102 | Feb 2026 | 109,349 | — | $41.6M | +29.7% | 5.49% | EC |
| 6 | Roche Holding AG | 000000000 | Feb 2026 | 98,026 | NEW | $41.2M | — | 5.44% | EC |
| 7 | Merck & Co Inc | 58933Y105 | Feb 2026 | 324,173 | +16,988 | $38.5M | +1.2% | 5.08% | EC |
| 8 | Bristol-Myers Squibb Co | 110122108 | Feb 2026 | 563,654 | — | $32.2M | -8.3% | 4.25% | EC |
| 9 | Vertex Pharmaceuticals Inc | 92532F100 | Feb 2026 | 57,284 | -3,396 | $25.6M | -15.0% | 3.38% | EC |
| 10 | Gilead Sciences Inc | 375558103 | Feb 2026 | 188,375 | — | $25.3M | -9.7% | 3.34% | EC |
| 11 | Sanofi SA | 000000000 | Feb 2026 | 254,833 | NEW | $22.3M | — | 2.95% | EC |
| 12 | Thermo Fisher Scientific Inc | 883556102 | Feb 2026 | 42,998 | -4,192 | $21.2M | -13.9% | 2.79% | EC |
| 13 | Intuitive Surgical Inc | 46120E602 | Feb 2026 | 48,480 | — | $20.6M | -15.7% | 2.72% | EC |
| 14 | Stryker Corp | 863667101 | Feb 2026 | 54,948 | — | $16.8M | -21.3% | 2.21% | EC |
| 15 | Boston Scientific Corp | 101137107 | Feb 2026 | 341,451 | +47,110 | $16.5M | -27.1% | 2.18% | EC |
| 16 | Medtronic PLC | 000000000 | Feb 2026 | 185,134 | NEW | $13.7M | — | 1.80% | EC |
| 17 | Lonza Group AG | 000000000 | Feb 2026 | 21,010 | NEW | $13.4M | — | 1.77% | EC |
| 18 | Novo Nordisk A/S | 000000000 | Feb 2026 | 283,516 | NEW | $13.0M | — | 1.71% | EC |
| 19 | Abbott Laboratories | 002824100 | Feb 2026 | 146,112 | -90,441 | $12.5M | -54.6% | 1.65% | EC |
| 20 | Novartis AG | 000000000 | Feb 2026 | 83,123 | NEW | $12.5M | — | 1.65% | EC |
| 21 | Argenx SE | 04016X101 | Feb 2026 | 14,601 | -2,942 | $12.2M | -9.3% | 1.61% | EC |
| 22 | Royalty Pharma PLC | 000000000 | Feb 2026 | 215,358 | NEW | $12.0M | — | 1.58% | EC |
| 23 | Neurocrine Biosciences Inc | 64125C109 | Feb 2026 | 67,430 | +15,776 | $10.7M | +56.3% | 1.41% | EC |
| 24 | Mettler-Toledo International Inc | 592688105 | Feb 2026 | 8,731 | — | $10.3M | -13.6% | 1.36% | EC |
| 25 | Straumann Holding AG | 000000000 | Feb 2026 | 83,976 | NEW | $10.1M | — | 1.34% | EC |
| 26 | Quest Diagnostics Inc | 74834L100 | May 2026 | 50,412 | NEW | $9.8M | — | 1.30% | EC |
| 27 | Genmab A/S | 000000000 | Feb 2026 | 34,565 | NEW | $9.1M | — | 1.20% | EC |
| 28 | Edwards Lifesciences Corp | 28176E108 | Feb 2026 | 102,548 | -43,738 | $8.9M | -29.9% | 1.17% | EC |
| 29 | Zoetis Inc | 98978V103 | Feb 2026 | 109,362 | -91,247 | $8.5M | -67.7% | 1.12% | EC |
| 30 | Cooper Cos Inc/The | 216648501 | Feb 2026 | 128,221 | — | $7.8M | -26.8% | 1.04% | EC |
| 31 | CSL Ltd | 000000000 | Feb 2026 | 99,071 | NEW | $6.9M | — | 0.91% | EC |
| 32 | HeartFlow Inc | 42238D107 | Feb 2026 | 218,978 | — | $6.8M | +33.8% | 0.90% | EC |
| 33 | Danaher Corp | 235851102 | Feb 2026 | 37,052 | — | $6.8M | -13.3% | 0.89% | EC |
| 34 | Recordati Industria Chimica e Farmaceutica SpA | 000000000 | Feb 2026 | 91,672 | NEW | $5.5M | — | 0.73% | EC |
| 35 | Xenon Pharmaceuticals Inc | 98420N105 | Feb 2026 | 100,149 | +48,772 | $5.5M | +146.8% | 0.72% | EC |
| 36 | Generate Biomedicines Inc | 370920100 | May 2026 | 312,500 | NEW | $4.1M | — | 0.54% | EC |
| 37 | Apogee Therapeutics Inc | 03770N101 | Feb 2026 | 33,655 | — | $2.8M | +17.3% | 0.36% | EC |
| 38 | Newamsterdam Pharma Co NV | 000000000 | Feb 2026 | 81,652 | NEW | $2.8M | — | 0.36% | EC |
| 39 | Morgan Stanley & Co. LLC | 61747C707 | Feb 2026 | 2,320,259 | +2,077,479 | $2.3M | +855.7% | 0.31% | STIV |
| 40 | Caris Life Sciences Inc | 142152107 | Feb 2026 | 135,807 | — | $2.3M | -17.0% | 0.30% | EC |
| 41 | EssilorLuxottica SA | 000000000 | Feb 2026 | 10,648 | NEW | $2.2M | — | 0.28% | EC |
| 42 | MBX Biosciences Inc | 55287L101 | May 2026 | 59,688 | NEW | $1.9M | — | 0.25% | EC |
| ✕ | McKesson Corp | 58155Q103 | — | 6,322 | SOLD | $6.2M | — | — | — |
| ✕ | Bio-Techne Corp | 09073M104 | — | 100,598 | SOLD | $5.9M | — | — | — |
| ✕ | Option Care Health Inc | 68404L201 | — | 178,995 | SOLD | $5.8M | — | — | — |
| ✕ | Centessa Pharmaceuticals PLC | 152309100 | — | 91,966 | SOLD | $2.5M | — | — | — |